Familial Adenomatous Polyposis - Pipeline Review, H2 2018

Familial Adenomatous Polyposis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Familial Adenomatous Polyposis (Genetic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.